483
Kavis Pharma LLCFDA 483 - Kavis Pharma LLC - April 09, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Kavis Pharma LLC in Sugar Land, TX, a manufacturer of non-sterile drug products, revealed significant deficiencies. Observations included inadequate procedures for preventing objectionable microorganisms in drug products, failure to ensure backup data integrity for the automated water system, and a lack of systems to comply with DSCSA verification requirements.
Open in Dashboard
ID · 1fd3fa56-811e-45c5-ba1c-9065e86f21dd